Sustainable Medicines Manufacturing: Expression of interest
Up to £1 million available for expression of interest (EoI) projects for Grand Challenges in sustainable medicines manufacturing.
The Sustainable Medicines Manufacturing Innovation programme will focus on innovation in pharmaceutical manufacturing to improve the manufacturing innovation ecosystem in the UK towards a sustainable future.
Sustainable medicines manufacturing, strives for the production of medicines in a manner that minimises environmental impact, conserves natural resources, and ensures economic and social sustainability.
Registrations close 16 October 2024
The aim of this competition is to provide seed funding to establish a consortium and prepare a case for a later, full sustainable medicine manufacturing themed Grand Challenge award. A Grand Challenge is a large-scale collaborative research and development (CR&D) award, up to £10 million, involving at least three partners across the medicines manufacturing supply chain.
We define sustainable medicines manufacturing as the process of producing medicines in a manner that minimises environmental impact, conserves natural resources, and ensures economic and social sustainability. This approach focuses on reducing waste, energy consumption and emissions, while enhancing efficiency, safety and cost-effectiveness throughout the manufacturing lifecycle. It also includes the adoption of innovative technologies and practices that promote the long-term viability of the medicines manufacturing industry.
This competition will help unlock potential by giving organisations the capacity to collaborate in developing new innovations, technologies, tools, data sets and approaches that can ultimately contribute to a sustainable medicines manufacturing sector.